List of works - Heather Wakelee

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

50 Years of progress in the systemic therapy of non-small cell lung cancer

scientific article

A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer ⬇️

scientific article published on November 1, 2010

A case series of lengthy progression-free survival with pemetrexed-containing therapy in metastatic non--small-cell lung cancer patients harboring ROS1 gene rearrangements

scientific article

A double-blind randomized discontinuation phase-II study of sorafenib (BAY 43-9006) in previously treated non-small-cell lung cancer patients: eastern cooperative oncology group study E2501.

scientific article

A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors ⬇️

scientific article published on December 11, 2011

A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies

scientific article

A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer

scientific article

Activity of novel cytotoxic agents in lung cancer: epothilones and topoisomerase I inhibitors.

scientific article

Adjuvant chemotherapy for early stage non-small cell lung cancer

scientific article

Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC).

scientific article

Adjuvant therapy for EGFR mutant and ALK positive NSCLC: Current data and future prospects

scientific article

American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.

scientific article

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

scientific article

Angiogenesis inhibitors

scientific article

Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial

scientific article

Diffuse high intensity PD-L1 staining in thymic epithelial tumors

scientific article

Docetaxel in advanced non-small cell lung cancer.

scientific article

Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interaction

scientific article published on 22 June 2015

Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies

scientific article

Integrated digital error suppression for improved detection of circulating tumor DNA

scientific article

Integrating Electronic Health Record, Cancer Registry, and Geospatial Data to Study Lung Cancer in Asian American, Native Hawaiian, and Pacific Islander Ethnic Groups

scientific article published on 17 May 2021

Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips.

scientific article

KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition

scientific article published on 18 October 2020

Lung Cancer Survival Among Chinese Americans, 2000 to 2010.

scientific article

Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial

scientific article

Lung cancer incidence in never smokers

journal article published in 2007

Lung cancer presenting with amegakaryocytic thrombocytopenia

scientific article

Management of early stage non-small cell lung cancer

scientific article

Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non–Small-Cell Lung Cancer ⬇️

scientific article published on June 24, 2011

Novel Treatments for Thymoma and Thymic Carcinoma.

scientific article

Novel approaches for the treatment of small cell lung cancer

scientific article published on April 2004

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

scientific article

Optimizing first-line treatment options for patients with advanced NSCLC.

scientific article

Pemetrexed disodium for the treatment of NSCLC: an update

scientific article

Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: The Women's Health Initiative

scientific article

Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?

scientific article published on December 2016

Pruritus as a Paraneoplastic Symptom of Thymoma

scientific article

Relationship of Driver Oncogenes to Long-Term Pemetrexed Response in Non--Small-Cell Lung Cancer

scientific article published on 31 December 2014

Reply to Comment on 'Statin use and all-cancer survival: prospective results from the Women's Health Initiative'.

scientific article

Rociletinib in EGFR-mutated non-small-cell lung cancer

scientific article

Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directions

scientific article

Second- and third-line treatments in non-small cell lung cancer

scientific article

Statin use and all-cancer survival: prospective results from the Women's Health Initiative

scientific article published on 09 June 2016

Sunitinib: a newly approved small-molecule inhibitor of angiogenesis

scientific article published on June 2006

Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.

scientific article

Survival following Non–Small Cell Lung Cancer among Asian/Pacific Islander, Latina, and Non-Hispanic White Women Who Have Never Smoked ⬇️

scientific article published on January 14, 2011

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

scientific article

Targeting angiogenesis with vascular endothelial growth factor receptor small-molecule inhibitors: novel agents with potential in lung cancer

scientific article

US phase 1 first-in-human study of taletrectinib (DS-6051b/AB-106), a ROS1/TRK inhibitor, in patients with advanced solid tumors

scientific article published on 26 June 2020

Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules

scientific article

List of works by Heather Wakelee

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

50 Years of progress in the systemic therapy of non-small cell lung cancer

A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer ⬇️

A case series of lengthy progression-free survival with pemetrexed-containing therapy in metastatic non--small-cell lung cancer patients harboring ROS1 gene rearrangements

A double-blind randomized discontinuation phase-II study of sorafenib (BAY 43-9006) in previously treated non-small-cell lung cancer patients: eastern cooperative oncology group study E2501.

A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors ⬇️

A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies

A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer

Activity of novel cytotoxic agents in lung cancer: epothilones and topoisomerase I inhibitors.

Adjuvant chemotherapy for early stage non-small cell lung cancer

Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC).

Adjuvant therapy for EGFR mutant and ALK positive NSCLC: Current data and future prospects

American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

Angiogenesis inhibitors

Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial

Diffuse high intensity PD-L1 staining in thymic epithelial tumors

Docetaxel in advanced non-small cell lung cancer.

Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interaction

Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies

Integrated digital error suppression for improved detection of circulating tumor DNA

Integrating Electronic Health Record, Cancer Registry, and Geospatial Data to Study Lung Cancer in Asian American, Native Hawaiian, and Pacific Islander Ethnic Groups

Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips.

KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition

Lung Cancer Survival Among Chinese Americans, 2000 to 2010.

Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial

Lung cancer incidence in never smokers

Lung cancer presenting with amegakaryocytic thrombocytopenia

Management of early stage non-small cell lung cancer

Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non–Small-Cell Lung Cancer ⬇️

Novel Treatments for Thymoma and Thymic Carcinoma.

Novel approaches for the treatment of small cell lung cancer

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

Optimizing first-line treatment options for patients with advanced NSCLC.

Pemetrexed disodium for the treatment of NSCLC: an update

Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: The Women's Health Initiative

Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?

Pruritus as a Paraneoplastic Symptom of Thymoma

Relationship of Driver Oncogenes to Long-Term Pemetrexed Response in Non--Small-Cell Lung Cancer

Reply to Comment on 'Statin use and all-cancer survival: prospective results from the Women's Health Initiative'.

Rociletinib in EGFR-mutated non-small-cell lung cancer

Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directions

Second- and third-line treatments in non-small cell lung cancer

Statin use and all-cancer survival: prospective results from the Women's Health Initiative

Sunitinib: a newly approved small-molecule inhibitor of angiogenesis

Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.

Survival following Non–Small Cell Lung Cancer among Asian/Pacific Islander, Latina, and Non-Hispanic White Women Who Have Never Smoked ⬇️

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

Targeting angiogenesis with vascular endothelial growth factor receptor small-molecule inhibitors: novel agents with potential in lung cancer

US phase 1 first-in-human study of taletrectinib (DS-6051b/AB-106), a ROS1/TRK inhibitor, in patients with advanced solid tumors

Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules